PRAX vs EXEL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

PRAX

60.6
AI Score
VS
PRAX Wins

EXEL

37.9
AI Score

Investment Advisor Scores

PRAX

61score
Recommendation
STRONG BUY

EXEL

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PRAX EXEL Winner
Forward P/E 0 13.5501 Tie
PEG Ratio 0 2.2685 Tie
Revenue Growth 1349.1% 10.6% PRAX
Earnings Growth 0.0% 26.2% EXEL
Tradestie Score 60.6/100 37.9/100 PRAX
Profit Margin 0.0% 35.3% EXEL
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY AVOID NEW MONEY PRAX

Relative Price Performance (Last 90 Days)

PRAX 1M: -8.2% · 3M: -20.4% EXEL 1M: +15.1% · 3M: +18.0%

Current Technical Phase

PRAX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.9%), weak momentum, RSI 40

RSI (14): 40.4 · Price: $258.92

EXEL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.0% over 20 days), RSI 76

RSI (14): 76.4 · Price: $65.31

Fundamentals Snapshot

Metric PRAX EXEL
Market Cap — —
Forward P/E -27.3 15.3
Trailing P/E — 20.4
Revenue (TTM) — —
Revenue Growth 13.5% 0.1%
Gross Margin -39.0% 1.0%
Operating Margin 0.0% 0.4%
EPS -12.95 3.17
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PRAX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.